Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation

Abstract

Over the decades, conventional in vitro culture systems and animal models have been used to study physiology, nutrient or drug metabolisms including mechanical and physiopathological aspects. However, there is an urgent need for Integrated Testing Strategies (ITS) and more sophisticated platforms and devices to approach the real complexity of human physiology and provide reliable extrapolations for clinical investigations and personalized medicine. Organ-on-a-chip (OOC), also known as a microphysiological system, is a state-of-the-art microfluidic cell culture technology that sums up cells or tissue-to-tissue interfaces, fluid flows, mechanical cues, and organ-level physiology, and it has been developed to fill the gap between in vitro experimental models and human pathophysiology. The wide range of OOC platforms involves the miniaturization of cell culture systems and enables a variety of novel experimental techniques. These range from modeling the independent effects of biophysical forces on cells to screening novel drugs in multi-organ microphysiological systems, all within microscale devices. As in living biosystems, the development of vascular structure is the salient feature common to almost all organ-on-a-chip platforms. Herein, we provide a snapshot of this fast-evolving sophisticated technology. We will review cutting-edge developments and advances in the OOC realm, discussing current applications in the biomedical field with a detailed description of how this technology has enabled the reconstruction of complex multi-scale and multifunctional matrices and platforms (at the cellular and tissular levels) leading to an acute understanding of the physiopathological features of human ailments and infections in vitro.

Circulating microRNAs as promising testicular translatable safety biomarkers: current state and future perspectives

“…One of the challenges for difficulty in preclinical to clinical translation of testicular toxicity can be attributed to the physiological and metabolic differences between the species. With the cutting-edge technologies such as 'organs-on-chips' (Zommiti et al 2022) that can emulate the human organ's physiological environment and function, there is potential to enhance our understanding of the translatability of biomarker miRNAs from nonclinical to clinical settings (Akinjo et al 2018;Park et al 2022). Leveraging such emerging tools will enable biomarker discovery, validation and clinical translation for regulatory qualification and implementation for a specific context of use in drug development.…”

Bitter taste receptors in the reproductive system: Function and therapeutic implications

“…Similarly, in vitro TAS2R knockdown in human uterine strips will allow us to investigate whether the relaxation effect of bitter tastants is mediated by TAS2Rs. Additionally, the recent combination of organoid culture, a method that produces miniaturized and simplified versions of organs, with microfluidic technology has led to the development of a ‘human‐on‐a‐chip’ platform (Zommiti et al, 2022). This platform enables high‐throughput clinical applications, drug discovery, and toxicology studies.…”

Bioengineering approaches for the endometrial research and application

“…They can be used to illustrate cellular interactions by studying the mechanisms that produce these microscopic properties, particularly the shear forces and concentration gradients in the surroundings. To date, the design of microfluidic technologies has been developed from simple chip platforms with only the cell types to multicellular chambers representing the entire organ system [ 42 , 43 ].…”